Sword Bio
PrivateLast Round
Seed
Jun 26, 2025
Est. Valuation
$11.7M
Total Funding Raised
$1.7M
Company Overview
Sword Bio is a biotechnology company that operates as a bioanalytical contract research organization (CRO) providing assay development, validation, and sample analysis services to support pharmaceutical and biotech companies in drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sword Bio Comparables
Compare Sword Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NorthEast BioAnalytical Laboratories LLC | 88% | |
| Meadowhawk Biolabs, Inc. | 85% | |
| Alturas Analytics, Inc. | 82% |
Sword Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 26, 2025 | ||||
| Pre Seed | Jun 26, 2023 | ||||
| Series B | Mar 5, 2007 | ||||
| Series A | Oct 13, 2006 |
Sword Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jumpstart NJ Angel Network | Angel, Pre Seed |
| Keiretsu Forum | Angel, Pre Seed |
| Elevate Ventures | Angel, Pre Seed |
| Tech Council Ventures | Angel, Pre Seed, Series A, Series B |
| Heartland Angels | Angel, Pre Seed |
| Angel Physicians Fund | Pre Seed |
| Calvert Research and Management | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2025
$4M raised in Seed round.
- Jun 26, 2023
$50K round from Elevate Ventures and Tech Council Ventures.
Sword Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sword Bio's valuation, stock price, and market status.
Is Sword a public or private company?
Sword is a private company.
What is the current stock price of Sword?
Sword is a private company with no public stock price. No recent secondary market data is available.
How much is Sword worth (valuation)?
Valuation information for Sword is not publicly available.
Can I buy Sword stock?
Sword shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sword's last funding round?
Sword's most recent funding round was Series B on March 5, 2007.
Who are the main investors in Sword?
Key investors in Sword include Jumpstart NJ Angel Network, Keiretsu Forum, Elevate Ventures, Tech Council Ventures, Heartland Angels.
Will Sword IPO soon?
No public IPO plans have been announced for Sword.
How can I track Sword secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sword's secondary market activity and sign up for updates.